Prostate Cancer of Biopsy Gleason Score 3+4=7 with Less than 5% of Gleason Pattern 4 Component Is Associated with Significantly Lower Incidence of Adverse Pathology in Japanese Cohort: Suggestion for Active Surveillance Criteria

被引：0
|
作者：
Sato, Shun [1 ]
Kimura, Takahiro [2 ]
Yorozu, Takashi [2 ]
Ikegami, Masahiro [2 ]
Takahashi, Hiroyuki [2 ]
机构：
[1] Jikei Univ, Sch Med, Minato Ku, Tokyo, Japan
[2] Jikei Univ, Sch Med, Tokyo, Japan
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1068
引用
收藏
页码：382 / 383
页数：2
相关论文
共 50 条
  • [21] FATE OF PATHOLOGICAL GLEASON SCORE 7 (3+4) IN CANDIDATES FOR ACTIVE SURVEILLANCE; ROYAL MARSDEN HOSPITAL CRITERIA
    Jo, Jung Ki
    Lee, In Jae
    Kim, Tae Jin
    Kim, Kwang Mo
    Lee, Young Ik
    Lee, Hakmin
    Lee, Sangchul
    Jeong, Seong Jin
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    Oh, Jong Jin
    JOURNAL OF UROLOGY, 2015, 193 (04): : E994 - E994
  • [22] Gleason score 7 prostate cancer on needle biopsy: Is the prognostic difference in Gleason scores 4+3 and 3+4 independent of the number of involved cores?
    Makarov, DV
    Sanderson, H
    Partin, AW
    Epstein, JI
    JOURNAL OF UROLOGY, 2002, 167 (06): : 2440 - 2442
  • [23] Favorable Gleason 3+4 Prostate Cancer Shows Comparable Outcomes With Gleason 3+3 Prostate Cancer: Implications for the Expansion of Selection Criteria for Active Surveillance
    Lee, Hakmin
    Lee, In Jae
    Byun, Seok-Soo
    Lee, Sang Eun
    Hong, Sung Kyu
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E1117 - E1122
  • [24] Gleason Score 3+4=7 Prostate Cancer with Minimal Pattern 4 Identified in Prostate Needle Biopsy Barely has Worse Pathological Outcomes
    Serrano, Antonio
    Melamed, Jonathan
    Ren, Qinghu
    Huang, Hongying
    Park, Kyung
    Flaifel, Abdallah
    Deng, Fangming
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 969 - 971
  • [25] Gleason Score 3+4=7 Prostate Cancer with Minimal Pattern 4 Identified in Prostate Needle Biopsy Barely has Worse Pathological Outcomes
    Serrano, Antonio
    Melamed, Jonathan
    Ren, Qinghu
    Huang, Hongying
    Park, Kyung
    Flaifel, Abdallah
    Deng, Fangming
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 969 - 971
  • [26] Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy
    De Luca, Stefano
    Fiori, Cristian
    Bollito, Enrico
    Garrou, Diletta
    Aimar, Roberta
    Cattaneo, Giovanni
    De Cillis, Sabrina
    Manfredi, Matteo
    Tota, Daniele
    Federica, Massa
    Passera, Roberto
    Porpiglia, Francesco
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (03) : 360 - 368
  • [27] Significance of the Percentage of Gleason Pattern 4 at Prostate Biopsy in Predicting Adverse Pathology on Radical Prostatectomy: Application in Active Surveillance
    Ordner, Jeffrey
    Flaifel, Abdallah
    Serrano, Antonio
    Graziano, Rebecca
    Melamed, Jonathan
    Deng, Fang-Ming
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 (01) : 35 - 40
  • [28] Prostate cancer patients with overall and highest biopsy Gleason score 3+4=7 have similar outcome
    Verhoef, E.
    Kweldam, C.
    Kummerlin, I.
    Nieboer, D.
    Steyerberg, E.
    Bangma, C.
    Roobol, M.
    van Leenders, A.
    VIRCHOWS ARCHIV, 2017, 471 : S276 - S277
  • [29] CANCER OF THE PROSTATE RISK ASSESSMENT SCORE FOLLOWING BIOPSY GLEASON UPGRADE DURING PROSTATE CANCER ACTIVE SURVEILLANCE IS ASSOCIATED WITH ADVERSE PATHOLOGY AT PROSTATECTOMY
    Leapman, Michael
    Ameli, Niloufar
    Chu, Carissa
    Hussein, Ahmed
    Welty, Christopher
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2015, 193 (04): : E513 - E513
  • [30] Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3+4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance
    Gearman, Derek J.
    Morlacco, Alessandro
    Cheville, John C.
    Rangel, Laureano J.
    Karnes, R. Jeffrey
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1188 - 1195
12345